Publications by authors named "W Schneider"

White matter alterations are increasingly implicated in neurological diseases and their progression. International-scale studies use diffusion-weighted magnetic resonance imaging (DW-MRI) to qualitatively identify changes in white matter microstructure and connectivity. Yet, quantitative analysis of DW-MRI data is hindered by inconsistencies stemming from varying acquisition protocols.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the growth rates of leftover vestibular schwannoma tumors after surgeries, and to create a staging system to predict the risk of this growth.
  • It involved a review of 56 patients who had undergone surgical resection between 2011 and 2023, finding that about 80% of residual tumors remained stable or shrank, while risk factors for growth included younger age and larger tumor sizes.
  • The proposed staging system (ATR) categorized tumors primarily into stages II and III, suggesting that initial monitoring after surgery could be effective for managing these patients, along with the need for long-term follow-up.
View Article and Find Full Text PDF

Ionic liquids (ILs) are a unique class of solvents with potential applications in advanced separation technologies relevant to the nuclear industry. ILs are salts with low melting points and a wide range of tunable physical properties, such as viscosity, hydrophobiciy, conductivity, and liquidus range. ILs have negligible vapor pressure, are often non-flammable, and can have high thermal stability and a wide electrochemical window, making them attractive for use in separations processes relevant to the nuclear industry.

View Article and Find Full Text PDF

The purpose of this study was to assess the performance of predictive blood biomarkers for responsiveness to targeted treatments for chronic psychological issues years after traumatic brain injury (TBI). Targeted Evaluation Action and Monitoring of TBI was a prospective 6-month interventional trial of participants with chronic TBI sequelae ( = 95). Plasma biomarkers were analyzed pre-intervention: glial fibrillary acidic protein (GFAP), tau, hyperphosphorylated tau Thr231 (p-Tau), von Willebrand factor (vWF), brain lipid-binding protein (BLBP), ubiquitin C-terminal hydrolase-L1 (UCH-L1), vascular endothelial growth factor-a (VEGFa), and claudin-5 (CLDN5).

View Article and Find Full Text PDF